Heart visualization and simulation
The tool lets users explore the heart from different angles, measure defects, and simulate implants.
Source: LinkedIn company description · Retrieved October 13, 2026
Vea is a 3D simulation tool intended to help doctors understand advanced congenital heart diseases.
Vea is intended solely for education and research and is not yet CE-certified or FDA-approved.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Vea is currently used by hospitals in 17 countries.
The tool lets users explore the heart from different angles, measure defects, and simulate implants.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 29, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.